Working on developing disruptive tools to revolutionize eye-care

As a trained optometrist, Patrick puts his in-depth understanding of the clinical care to the development of innovative technologies to revolutionize eye care and prevent vision loss. He is continuously contributing to clinical and innovative technological advancements to the field. Patrick is also a guest speaker at the school of optometry Université de Montréal, the university where he received his Doctor of Optometry (OD) degree and Master’s degree in Vision Science. He is an active member of the Association des Optométristes du Québec.

CEO, Co-Founder

Dr Patrick Sauvageau


CTO, Co-Founder

Dr Dominic Sauvageau

PhD PEng

Dominic is a chemical engineer with extensive experience working for the development of new technologies in industrial and academic environments for applications in biotechnology and bioengineering. He is associate Professor in the Department of Chemical and Materials Engineering at the University of Alberta, Dominic has a strong background and expertise in academic and industrial bioengineering.
Claude is an experienced leader and entrepreneur with 30+ years of experience in life sciences including clinical research, product development, sales, marketing, operations and business development. Claude also worked in the venture capital sector, playing a major role in the financing of numerous ventures.

Chairman of the Board

Claude Vezeau


Board of directors

Dr Dominique Meyer


Dominique is a certified Ophthalmologist and founder of a renowned private medical center. As an active clinical researcher in the field of ophthalmology, she provides valuable knowledge and insight in the development and application of Zilia’s technology.

Danny is a pharmacist-owner since 2002 and President of Gilbert Gobeil Martel Pharmacies, which is comprised of four pharmacies and 125 employees. Over the years, Danny has built a strong expertise in marketing, sales and business operations. He is also an active private investor in the healthcare sector.

Board of directors

Danny Gobeil



Scientific Advisory Board

Dr Ike Ahmed


Dr. Ahmed is a leader in novel treatments for glaucoma, cataract, and lens implant surgery. His pioneering work in glaucoma surgery includes developing microinvasive glaucoma surgery (MIGS). An assistant professor at the University of Toronto and a professor at the University of Utah, he is also research director at the Kensington Eye Institute and director of the Glaucoma and Advanced Anterior Segment Surgery (GAASS) fellowship, both at the University of Toronto. In addition, Dr. Ahmed is head of the ophthalmology division at Trillium Health Partners. He is recognized as one of the most experienced complex eye surgeons in the world.

Dr. Rajat N Agrawal is President and CEO of Retina Global, a not-for-profit organization addressing retinal diseases in underserved areas of the world, an Adjunct Professor at the Roski Eye Institute and a Visiting Professor at the Dept. of Ophthalmology at the University of Southern California. He is a world-renowned ophthalmologist and retina specialist. He has been involved in developing a number of medical devices, including the ARGUS-II which allows some blind patients to see again, and drugs for the treatment of ocular diseases. He holds a Masters in Regulatory Affairs and works as a consultant for pre-clinical and clinical research, and business and market evaluation. He has been an advisor for investments and acquisitions of early to late stage biomed opportunities, totalling over 50 million dollars.

Scientific Advisory Board

Dr Rajat N Agrawal


Scientific Advisory Board

Dr Daniel Chao


Dr Daniel L Chao is an Assistant Professor of Ophthalmology at the Shiley Eye Institute at the University of California, San Diego. He earned a BS in Biomedical Engineering at Virginia Commonwealth University and an M.D. and Ph.D. in Neurosciences at Stanford University. He completed his internship at Santa Clara Valley Medical Center, his ophthalmology residency at the Bascom Palmer Eye Institute, and his vitreoretinal surgery fellowship at the University of California, San Francisco. His research focuses on treatments of retinal diseases. He has participated in many clinical trials and is involved in interdisciplinary collaborations to develop novel imaging modalities and therapeutic approaches for retinal diseases.

Eric is a biomedical engineer with over 20 years of experience in developing and commercializing medical devices and biomedical applications. He is a guest professor at École Polytechnique and ÉTS.

Advisory Board

Dr Éric Desrosiers



Sébastien Bouchard


Business Development Director

Dario Zujo


Lead Engineer

Nicolas Lapointe


Clinical Application Specialist

Dr Joannie Desroches


Software Developer

Maxime Picard

Software Engineer

Samuel Bruneau-Dubuc


Biophotonics Scientist

Dr Cleophace Akitegetse

PhD PEng

Regulatory Affairs

Dr Diana Martínez


Imaging Specialist

Jasmine Poirier



ABOUT     TECHNOLOGY     TEAM     BLOG     CONTACT     FR 1.833.501.6996